87 related articles for article (PubMed ID: 19955699)
1. Low erythropoietin plasma levels during exacerbations of COPD.
Sala E; Balaguer C; Villena C; Ríos A; Noguera A; Núñez B; Agustí A
Respiration; 2010; 80(3):190-7. PubMed ID: 19955699
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease.
Markoulaki D; Kostikas K; Papatheodorou G; Koutsokera A; Alchanatis M; Bakakos P; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Eur J Intern Med; 2011 Feb; 22(1):103-7. PubMed ID: 21238904
[TBL] [Abstract][Full Text] [Related]
3. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.
Boutou AK; Pitsiou GG; Stanopoulos I; Kontakiotis T; Kyriazis G; Argyropoulou P
QJM; 2012 Jul; 105(7):657-63. PubMed ID: 22355163
[TBL] [Abstract][Full Text] [Related]
4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.
Chan KH; Yeung SC; Yao TJ; Ip MS; Cheung AH; Chan-Yeung MM; Mak JC;
Int J Tuberc Lung Dis; 2010 Sep; 14(9):1193-200. PubMed ID: 20819268
[TBL] [Abstract][Full Text] [Related]
6. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
[TBL] [Abstract][Full Text] [Related]
7. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
8. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
9. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and inflammation - A further systemic complication of COPD.
Bolton CE; Evans M; Ionescu AA; Edwards SM; Morris RH; Dunseath G; Luzio SD; Owens DR; Shale DJ
COPD; 2007 Jun; 4(2):121-6. PubMed ID: 17530505
[TBL] [Abstract][Full Text] [Related]
13. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
17. [Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic obstructive pulmonary disease].
Tseĭmakh IIa; Momot AP; Kostiuchenko GI; Mamaev AN; Filonova IuA; Kornilova TA; Chuchalin AG
Ter Arkh; 2013; 85(3):17-22. PubMed ID: 23720837
[TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin secretion in patients with chronic obstructive lung diseases during normobaric oxygen inhalation].
Kokot F; Franek E; Kokot M; Wiecek A; Kozielski J; Rauer R; Oklek K
Cas Lek Cesk; 1994 May; 133(11):334-7. PubMed ID: 8004661
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
Antonescu-Turcu AL; Tomic R
Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
[TBL] [Abstract][Full Text] [Related]
20. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
